Parenteral Iron Therapy in Treatment of Anemia in End-Stage Renal Disease Patients: A Comparative Study between Iron Saccharate and Gluconate

Publisher： Karger

E-ISSN： 1660-2110|99|4|c97-c101

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.99, Iss.4, 2005-02, pp. : c97-c101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythrocyte Indices in the Assessment of Iron Status in Dialysis-Dependent Patients with End-Stage Renal Disease on Continuous Erythropoietin Receptor Activator versus Epoetin β Therapy

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 27-33

Karger

Access to resources Recommend Favorite

Diagnosis and Treatment of Low Testosterone among Patients with End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 3, 2015-05 ,pp. : 259-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antidiabetic Therapy in End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 337-344

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimising Treatment of End-Stage Renal Disease in the Elderly

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 202-208

Karger

Access to resources Recommend Favorite

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite